Symbol
| E2F1
| contributors: mct/shn - updated : 26-07-2022
|
HGNC name
| E2F transcription factor 1
|
HGNC id
| 3113
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in metastatic tissues from hormone-resistant prostate cancer patients | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | | | |
E2F1-DUSP2 cascade in cancer cell killing may provide a molecular basis for cancer therapeutic intervention | diabete | type 2 | | |
specifically targeting E2F1 in the liver could be an interesting strategy for therapies against type 2 diabetes |
| | | |
| E2f1-deficient mice exhibit defects in apoptosis and are rather prone to tumorigenesis |